Heights CareerTech Institute is set to open Aug. 5. Southwest Florida leads say the school will fill a workforce gap.
AbbVie today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell engaging bispecific antibody, and lenalidomide, compared to rituximab ...
Hundreds of people fill a downtown street for a protest, waving signs and chanting as they march past businesses and ...